Therapeutics News and Research

RSS

Experts in Parkinson's research propose roadmap for drug trials targeting alpha-synuclein

A recently discovered protein, alpha-synuclein, has become one of the most attractive targets for developing new drugs with the potential to slow down or arrest the progression of Parkinson's disease

20 Dec 2018

New study reveals how fatty diet can lead to serious form of liver disease

A new study by Keck School of Medicine of USC researchers shows there's yet another reason to avoid a high fat, high cholesterol diet: It can trigger changes in the immune system that lead to a serious form of non-alcoholic fatty liver disease known as non-alcoholic steatohepatitis.

20 Dec 2018

Study reveals how Parkinson's disease protein 'buys time' for cell repair

Australian researchers have discovered how a protein linked to Parkinson's disease may protect cells such as neurons in the brain.

20 Dec 2018

New drug could significantly slow progression of ALS, shows research

A new drug could significantly slow the progression of ALS, also known as Lou Gehrig's disease, according to new research by University of Alberta biologists. Current treatments slow progression of the degenerative disease by only a few months, and these findings could revolutionize the treatment of patients suffering from ALS, extending and improving quality of life.

18 Dec 2018

New therapy for childhood blindness shows 'very promising' results

A new therapy aimed at improving the sight of people with one of the most common forms of childhood blindness, has shown 'very promising' initial results, according to a study involving UCL researchers.

18 Dec 2018

New $1.6 million NIH grant supports study on a gene vital to circadian rhythms

Circadian rhythms (from the Latin circa diem -- "around a day") based on the Earth's 24-hour rotation have been observed since the fourth century.

18 Dec 2018

Intraocular injection improves vision in a form of congenital retinal blindness

A new treatment for patients with a form of congenital retinal blindness has shown success in improving vision, according to results published today in Nature Medicine led by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania.

18 Dec 2018

Study finds epigenetic differences in the brains of individuals with schizophrenia

A study using a PET scan tracer developed at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital has identified, for the first time, epigenetic differences between the brains of individuals with schizophrenia and those of unaffected study participants.

17 Dec 2018

Exercise-induced hormone activates cells critical for bone remodeling in mice

Exercise has been touted to build bone mass, but exactly how it actually accomplishes this is a matter of debate. Now, researchers show that an exercise-induced hormone activates cells that are critical for bone remodeling in mice.

14 Dec 2018

Johns Hopkins researchers identify molecular causes of necrotizing enterocolitis in preemies

Using a mouse model of necrotizing enterocolitis -- a potentially fatal condition that causes a premature infant's gut to suddenly die -- researchers at Johns Hopkins say they have uncovered the molecular causes of the condition and its associated brain injury.

14 Dec 2018

Virginia Tech and UC San Diego researchers team up to develop nonopioid drug for chronic pain

Researchers from the Virginia Tech School of Neuroscience are teaming with the University of California San Diego and the U.S. National Institutes of Health to develop a drug -- now in its earliest stages -- that can treat certain types of chronic pain without the addictive consequences of opioids.

12 Dec 2018

IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony

Dr. John McCafferty celebrates the success of phage display technology with Nobel Prize in Chemistry Laureates.

From FairJourney Biologics 12 Dec 2018

Findings may open up new ways to treat dwarfism and other ER-stress-related conditions

Pseudoachondroplasia (PSACH) is a severe inherited dwarfing condition characterized by disproportionate short stature, joint laxity, pain, and early onset osteoarthritis.

12 Dec 2018

Integral Molecular and Merus collaborate to develop bispecific antibody therapeutics

Integral Molecular, the industry leader in the discovery of monoclonal antibodies against membrane proteins, and Merus N.V., a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, announced that they have entered into a collaboration on multiple undisclosed targets.

12 Dec 2018

ESMO Immuno-Oncology Congress showcases novel technologies set to benefit many cancer patients

Innovation in immuno-oncology is exploding and new technologies that are set to benefit many patients with cancer are being showcased in the highly diverse array of topics to be discussed at the ESMO Immuno-Oncology Congress, to be held 13-16 December in Geneva, Switzerland.

11 Dec 2018

Researchers identify immune cell subset that may drive chronic inflammation

For the first time, researchers have identified that an immune cell subset called gamma delta T cells that may be causing and/or perpetuating the systemic inflammation found in normal aging in the general geriatric population and in HIV-infected people who are responding well to drugs (anti-retrovirals).

11 Dec 2018

Therapeutics News and Research

Experts in Parkinson's research propose roadmap for drug trials targeting alpha-synuclein

New study reveals how fatty diet can lead to serious form of liver disease

Study reveals how Parkinson's disease protein 'buys time' for cell repair

New drug could significantly slow progression of ALS, shows research

New therapy for childhood blindness shows 'very promising' results

New $1.6 million NIH grant supports study on a gene vital to circadian rhythms

Intraocular injection improves vision in a form of congenital retinal blindness

Study finds epigenetic differences in the brains of individuals with schizophrenia

Exercise-induced hormone activates cells critical for bone remodeling in mice

Johns Hopkins researchers identify molecular causes of necrotizing enterocolitis in preemies

Virginia Tech and UC San Diego researchers team up to develop nonopioid drug for chronic pain

IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony

Findings may open up new ways to treat dwarfism and other ER-stress-related conditions

Integral Molecular and Merus collaborate to develop bispecific antibody therapeutics

ESMO Immuno-Oncology Congress showcases novel technologies set to benefit many cancer patients

Researchers identify immune cell subset that may drive chronic inflammation

Research findings could lead to new targets for cancer-fighting therapeutics

The Microbiome Movement announce Microbiotica as official industry partner

Researchers capture high-resolution X-ray and NMR image of key immune regulator

FDA clears mobile medical app to help increase retention in recovery program for opioid use disorder

Next-generation therapeutics eBook eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News